Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents

Bioorg Med Chem. 2015 Oct 1;23(19):6237-45. doi: 10.1016/j.bmc.2015.08.043. Epub 2015 Sep 2.

Abstract

A number of heterocycles bearing an arylpiperazinylalkyl side chain and structurally related to the previously described lead ET1 (4-amino-6-methyl-2-[3-(4-p-tolylpiperazin-1-yl)propyl]-5-vinylpyridazin-3(2H)-one) was synthesized and tested for their antinociceptive activity in Writhing Test. Many compounds, tested at doses of 20-40 mg/kg po were able to reduce the number of abdominal constrictions by more than 47% and, in same cases, the potency is comparable to lead ET1 as for 5e, 24a, 27b and 27c. The analgesia induced by the active compounds was completely prevented by pretreatment with α2-antagonist yohimbine, confirming the involvement of the adrenergic system in the mechanism of action for these new compounds.

Keywords: Adrenergic system; Antinociception; Synthesis.

MeSH terms

  • Acetic Acid / toxicity
  • Administration, Oral
  • Adrenergic alpha-2 Receptor Antagonists / pharmacology
  • Analgesics / chemical synthesis*
  • Analgesics / chemistry
  • Analgesics / therapeutic use
  • Animals
  • Heterocyclic Compounds / chemical synthesis
  • Heterocyclic Compounds / chemistry*
  • Heterocyclic Compounds / therapeutic use
  • Mice
  • Pain / chemically induced
  • Pain / drug therapy
  • Pyridazines / chemistry
  • Yohimbine / pharmacology

Substances

  • Adrenergic alpha-2 Receptor Antagonists
  • Analgesics
  • Heterocyclic Compounds
  • Pyridazines
  • Yohimbine
  • Acetic Acid